{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:31:30Z","timestamp":1793082690977,"version":"4.5.0"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.cca.2025.120418","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T02:29:52Z","timestamp":1749263392000},"page":"120418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Beta-2 microglobulin in lymphoma"],"prefix":"10.1016","volume":"576","author":[{"given":"Gaurav","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahsas","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"PadmaPriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kattela","family":"Chennakesavulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswaranjan","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rekha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avijit","family":"Mazumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haider","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moyad","family":"Shahwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cca.2025.120418_b0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4103\/0973-029X.294653","article-title":"Diagnosis of malignant lymphoma\u2013an overview","volume":"24","author":"Nirmal","year":"2020","journal-title":"J. Oral Maxillofacial Pathol."},{"issue":"4","key":"10.1016\/j.cca.2025.120418_b0010","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.4103\/jfmpc.jfmpc_1037_19","article-title":"Non-hodgkin's lymphoma: a review","volume":"9","author":"Singh","year":"2020","journal-title":"J. Family Med. Prim. Care"},{"key":"10.1016\/j.cca.2025.120418_b0015","first-page":"489","article-title":"Global patterns and trends in the incidence of non-hodgkin lymphoma","volume":"30","author":"Miranda-Filho","year":"2019","journal-title":"Can. Causes Control"},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0020","article-title":"Analysis of risk factors for lymph nodal involvement in early stages of rectal cancer: when can local excision be considered an appropriate treatment? systematic review and meta\u2010analysis of the literature","volume":"2012","author":"Carrara","year":"2012","journal-title":"Int. J. Surg. Oncol."},{"key":"10.1016\/j.cca.2025.120418_b0025","doi-asserted-by":"crossref","unstructured":"P. Ruscitti, Y. Allanore, C. Baldini, G. Barilaro, E.B. Bocci, P. Bearzi, E. Bellis, O. Berardicurti, A. Biaggi, M. Bombardieri, Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus, Autoimmunity reviews (2024) 103581.","DOI":"10.1016\/j.autrev.2024.103581"},{"issue":"9","key":"10.1016\/j.cca.2025.120418_b0030","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.5858\/2004-128-1004-AOFCAI","article-title":"Applications of flow cytometry and immunohistochemistry to diagnostic hematopathology","volume":"128","author":"Dunphy","year":"2004","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"18","key":"10.1016\/j.cca.2025.120418_b0035","first-page":"4153","article-title":"Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)","volume":"113","author":"Bassan","year":"2009","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"2","key":"10.1016\/j.cca.2025.120418_b0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000101712","article-title":"Diagnosis and classification of malignant lymphoma and related entities in the bone marrow trephine biopsy","volume":"74","author":"Fend","year":"2007","journal-title":"Pathobiol. J. Immunopathol. Mol. Cell. Biol."},{"key":"10.1016\/j.cca.2025.120418_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02656-7","article-title":"Non-invasive biomarkers for monitoring the immunotherapeutic response to cancer","volume":"18","author":"Nisar","year":"2020","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/s24010037","article-title":"Biomarkers in cancer detection, diagnosis, and prognosis","volume":"24","author":"Das","year":"2023","journal-title":"Sensors"},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jjco\/hys194","article-title":"Prognostic value of C-reactive protein, lactase dehydrogenase and anemia in recurrent or refractory aggressive lymphoma","volume":"43","author":"Suzuki","year":"2013","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0060","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1192\/j.eurpsy.2023.2417","article-title":"Predicting antipsychotic-induced weight gain in first episode psychosis \u2013 a field-wide systematic review and meta-analysis of non-genetic prognostic factors","volume":"66","author":"Fitzgerald","year":"2023","journal-title":"Eur. Psychiatry"},{"issue":"4","key":"10.1016\/j.cca.2025.120418_b0065","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/bjc.1993.144","article-title":"Beta-2 microglobulin: a prognostic factor in diffuse aggressive non-hodgkin's lymphomas","volume":"67","author":"Johnson","year":"1993","journal-title":"Br. J. Can."},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/2643-3230.BCD-21-0029","article-title":"Circulating tumor DNA in lymphoma: principles and future directions","volume":"3","author":"Roschewski","year":"2022","journal-title":"Blood Can. Discov."},{"key":"10.1016\/j.cca.2025.120418_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.763790","article-title":"Circulating tumor DNA and minimal residual disease (MRD) in solid tumors: current horizons and future perspectives","volume":"11","author":"Peng","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13045-025-01673-7","article-title":"Circulating tumor DNA in lymphoma: technologies and applications","volume":"18","author":"Fu","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0085","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/hon.2188","article-title":"Serum beta\u20102 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma","volume":"34","author":"Yoo","year":"2016","journal-title":"Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.cca.2025.120418_b0090","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1084\/jem.182.3.639","article-title":"Antigen presentation to cytotoxic T lymphocytes in vivo","volume":"182","author":"Bevan","year":"1995","journal-title":"J. Exp. Med."},{"issue":"1\u20132","key":"10.1016\/j.cca.2025.120418_b0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.drudis.2008.11.001","article-title":"\u03b22-microglobulin: emerging as a promising cancer therapeutic target","volume":"14","author":"Shi","year":"2009","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/hon.2188","article-title":"Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma","volume":"34","author":"Yoo","year":"2016","journal-title":"Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.cca.2025.120418_b0105","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/hon.2312","article-title":"Beta-2 microglobulin as a significant prognostic factor and a new risk model for patients with diffuse large B-cell lymphoma","volume":"35","author":"Kanemasa","year":"2017","journal-title":"Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0110","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s10238-024-01491-0","article-title":"lncRNAs as prognostic markers and therapeutic targets in cuproptosis-mediated cancer","volume":"24","author":"Bhat","year":"2024","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.cca.2025.120418_b0115","first-page":"108","article-title":"Antibody-drug conjugates (ADCs): a novel therapy for triple-negative breast cancer (TNBC)","author":"Gupta","year":"2025","journal-title":"Bentham Science Publishers"},{"issue":"5","key":"10.1016\/j.cca.2025.120418_b0120","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.70009","article-title":"CRBN\u2010PROTACs in cancer therapy: from mechanistic insights to clinical applications","volume":"104","author":"Thapa","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"issue":"7","key":"10.1016\/j.cca.2025.120418_b0125","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1158\/2159-8290.CD-20-0987","article-title":"CD4 T cell\u2013dependent rejection of Beta-2 microglobulin null mismatch repair\u2013deficient tumors","volume":"11","author":"Germano","year":"2021","journal-title":"Can. Discov."},{"issue":"6","key":"10.1016\/j.cca.2025.120418_b0130","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/bjh.14489","article-title":"Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of \u03b22-microglobulin yields a more accurate GELTAMO-IPI","volume":"176","author":"Montalb\u00e1n","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"12","key":"10.1016\/j.cca.2025.120418_b0135","doi-asserted-by":"crossref","first-page":"e7239","DOI":"10.1002\/cam4.7239","article-title":"Revisiting beta-2 microglobulin as a prognostic marker in diffuse large B-cell lymphoma","volume":"13","author":"Jelicic","year":"2024","journal-title":"Cancer Med."},{"issue":"3","key":"10.1016\/j.cca.2025.120418_b0140","first-page":"3992","article-title":"Association of \u03b22-microglobulin with the prognosis of non-hodgkin's lymphoma: a meta analysis","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"2","key":"10.1016\/j.cca.2025.120418_b0145","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pep.2006.08.001","article-title":"Construction of bioactive chimeric MHC class I tetramer by expression and purification of human\u2013murine chimeric MHC heavy chain and \u03b22m as a fusion protein in Escherichia coli","volume":"50","author":"Ren","year":"2006","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.cca.2025.120418_b0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-981-13-9367-9_2","article-title":"MHC molecules, T cell receptors, natural killer cell receptors, and viral immunoevasins\u2014key elements of adaptive and innate immunity","author":"Jiang","year":"2019","journal-title":"Struct. Immunol."},{"key":"10.1016\/j.cca.2025.120418_b0155","unstructured":"C.M. Gould, The impact of deficient antigen presentation on the tumour microenvironment of diffuse large B cell lymphoma, 2020."},{"key":"10.1016\/j.cca.2025.120418_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113675","article-title":"The role of CD95 in modulating CAR T-cell therapy: challenges and therapeutic opportunities in oncology","volume":"144","author":"Bhat","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cca.2025.120418_b0165","article-title":"The immune-related role of beta-2-microglobulin in melanoma","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.cca.2025.120418_b0170","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1158\/1078-0432.CCR-07-2063","article-title":"The prognostic significance of serum \u03b22 microglobulin levels in acute myeloid leukemia and prognostic scores predicting survival: analysis of 1,180 patients","volume":"14","author":"Tsimberidou","year":"2008","journal-title":"Clin. Can. Res."},{"issue":"2","key":"10.1016\/j.cca.2025.120418_b0175","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16020238","article-title":"Prognostic impact of serum \u03b2(2)-microglobulin levels in hodgkin lymphoma treated with ABVD or equivalent regimens: a comprehensive analysis of 915 patients","volume":"16","author":"Vassilakopoulos","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.cca.2025.120418_b0180","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1073\/pnas.72.2.548","article-title":"The structure and function of immunoglobulin domains: studies with beta-2-microglobulin on the role of the intrachain disulfide bond","volume":"72","author":"Isenman","year":"1975","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"15","key":"10.1016\/j.cca.2025.120418_b0185","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1073\/pnas.152337399","article-title":"Crystal structure of monomeric human \u03b2-2-microglobulin reveals clues to its amyloidogenic properties","volume":"99","author":"Trinh","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cca.2025.120418_b0190","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.biopha.2017.08.120","article-title":"IL-1\u03b2-induced NF-\u03baB activation down-regulates miR-506 expression to promotes osteosarcoma cell growth through JAG1","volume":"95","author":"Hu","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.cca.2025.120418_b0195","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0022-2836(03)00687-9","article-title":"A systematic investigation into the effect of protein destabilisation on Beta 2-microglobulin amyloid formation","volume":"330","author":"Smith","year":"2003","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0200","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1134\/S0022093025010120","article-title":"Nonspecific Interaction of immunoglobulins (IgG) with human Beta-2 microglobulin fibrils","volume":"61","author":"Polyakov","year":"2025","journal-title":"J. Evol. Biochem. Physiol."},{"issue":"2","key":"10.1016\/j.cca.2025.120418_b0205","first-page":"37","article-title":"Regulation of oncoprotein 18\/Stathmin signaling by ERK concerns the resistance to taxol in nonsmall cell lung cancer cells","volume":"31","author":"Lin","year":"2016","journal-title":"Can. Biother Radiopharm"},{"issue":"8","key":"10.1016\/j.cca.2025.120418_b0210","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.4049\/jimmunol.142.8.2796","article-title":"Role of beta 2-microglobulin in the intracellular transport and surface expression of murine class I histocompatibility molecules","volume":"142","author":"Williams","year":"1989","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cca.2025.120418_b0215","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14489","article-title":"A TGF-\u03b2 signaling-related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response","volume":"30","author":"Duan","year":"2024","journal-title":"CNS Neurosci Ther"},{"issue":"19","key":"10.1016\/j.cca.2025.120418_b0220","doi-asserted-by":"crossref","first-page":"7517","DOI":"10.1073\/pnas.87.19.7517","article-title":"Reassociation with beta 2-microglobulin is necessary for Kb class I major histocompatibility complex binding of exogenous peptides","volume":"87","author":"Rock","year":"1990","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.cca.2025.120418_b0225","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10637-024-01452-0","article-title":"Clinical characteristics, treatment and outcome of pembrolizumab-induced acute pancreatitis","volume":"42","author":"Luo","year":"2024","journal-title":"Invest New Drugs"},{"issue":"13","key":"10.1016\/j.cca.2025.120418_b0230","doi-asserted-by":"crossref","first-page":"6880","DOI":"10.1073\/pnas.94.13.6880","article-title":"The three-dimensional structure of an H-2L<sup>d<\/sup>-peptide complex explains the unique interaction of L<sup>d<\/sup> with beta-2 microglobulin and peptide","volume":"94","author":"Balendiran","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0235","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1038\/s41598-025-86664-x","article-title":"Clinical significance of PCT, CRP, IL-6, NLR, and TyG index in early diagnosis and severity assessment of acute pancreatitis: a retrospective analysis","volume":"15","author":"Xinyu","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2025.120418_b0240","doi-asserted-by":"crossref","unstructured":"J.L. Vigna, K.D. Smith, C.T. Lutz, Invariant chain association with MHC class I: preference for HLA class I\/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove, J. Immunol. (Baltimore, Md.: 1950) 157(10) (1996) 4503-4510.","DOI":"10.4049\/jimmunol.157.10.4503"},{"key":"10.1016\/j.cca.2025.120418_b0245","article-title":"Evaluation of a three-gene methylation model for correlating lymph node metastasis in postoperative early gastric cancer adjacent samples","volume":"14","author":"Chen","year":"2024","journal-title":"Front Oncol"},{"issue":"8","key":"10.1016\/j.cca.2025.120418_b0250","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/cgt.2014.32","article-title":"Adenovirus expressing \u03b22-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition","volume":"21","author":"del Campo","year":"2014","journal-title":"Can. Gene Ther."},{"issue":"12","key":"10.1016\/j.cca.2025.120418_b0255","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1007\/s00277-024-06119-7","article-title":"Construction of AML prognostic model with CYP2E1 and GALNT12 biomarkers based on golgi- associated genes","volume":"103","author":"Bin","year":"2024","journal-title":"Ann. Hematol."},{"issue":"4","key":"10.1016\/j.cca.2025.120418_b0260","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4103\/0366-6999.176084","article-title":"The implication and significance of beta 2 microglobulin: a conservative multifunctional regulator","volume":"129","author":"Li","year":"2016","journal-title":"Chin Med. J. (Engl)"},{"key":"10.1016\/j.cca.2025.120418_b0265","doi-asserted-by":"crossref","unstructured":"G. Gupta, M.S. Hussain, R. Thapa, R. Dahiya, D.K. Mahapatra, A.A. Bhat, N. Singla, V. Subramaniyan, S. Rawat, V. Jakhmola, Hope on the horizon: Wharton\u2019s jelly mesenchymal stem cells in the fight against COVID-19, Taylor & Francis, 2023, pp. 675\u2013678.","DOI":"10.2217\/rme-2023-0077"},{"key":"10.1016\/j.cca.2025.120418_b0270","article-title":"Epithelial\u2013mesenchymal transition to mitigate age-related progression in lung cancer","volume":"102576","author":"Thapa","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.cca.2025.120418_b0275","article-title":"The neutrophil-lymphocyte ratio predicts all-cause and cardiovascular mortality among United States adults with COPD: results from NHANES 1999-2018","volume":"11","author":"Chen","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.cca.2025.120418_b0280","doi-asserted-by":"crossref","unstructured":"Y.e. Liu, Y. Wang, Y. Yang, L. Weng, Q. Wu, J. Zhang, P. Zhao, L. Fang, Y. Shi, P. Wang, Emerging phagocytosis checkpoints in cancer immunotherapy, Signal transduction and targeted therapy 8(1) (2023) 104.","DOI":"10.1038\/s41392-023-01365-z"},{"issue":"13","key":"10.1016\/j.cca.2025.120418_b0285","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.3390\/ijms22136741","article-title":"MHC class I deficiency in solid tumors and therapeutic strategies to overcome it","volume":"22","author":"Shklovskaya","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2025.120418_b0290","doi-asserted-by":"crossref","first-page":"69","DOI":"10.25259\/Cytojournal_165_2024","article-title":"Association of immunosuppressive CD45(+)CD33(+)CD14(-) CD10(-)HLA-DR(-\/low) neutrophils with poor prognosis in patients with lymphoma and their expansion and activation through STAT3\/arginase-1 pathway in vitro","volume":"21","author":"Xiao","year":"2024","journal-title":"Cytojournal"},{"key":"10.1016\/j.cca.2025.120418_b0295","doi-asserted-by":"crossref","unstructured":"K.C. Parker, M. DiBrino, L. Hull, J. Coligan, The beta 2-microglobulin dissociation rate is an accurate measure of the stability of MHC class I heterotrimers and depends on which peptide is bound, J. Immunol. (Baltimore, Md.: 1950) 149(6) (1992) 1896-1904.","DOI":"10.4049\/jimmunol.149.6.1896"},{"issue":"12","key":"10.1016\/j.cca.2025.120418_b0300","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.4049\/jimmunol.148.12.3723","article-title":"Peptide and beta 2-microglobulin regulation of cell surface MHC class I conformation and expression","volume":"148","author":"Otten","year":"1992","journal-title":"J. Immunol."},{"issue":"187","key":"10.1016\/j.cca.2025.120418_b0305","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.24976\/Discov.Med.202436187.149","article-title":"TNFAIP3 overexpression inhibits diffuse Large B-cell lymphoma progression by promoting autophagy through TLR4\/MyD88\/NF-\u03baB signaling pathway","volume":"36","author":"Ning","year":"2024","journal-title":"Discov Med"},{"issue":"7","key":"10.1016\/j.cca.2025.120418_b0310","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1096\/fj.14-268094","article-title":"Dissociation of \u03b22-microglobulin determines the surface quality control of major histocompatibility complex class I molecules","volume":"29","author":"Montealegre","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.cca.2025.120418_b0315","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1285049","article-title":"Tumor beta2-microglobulin and HLA-A expression is increased by immunotherapy and can predict response to CIT in association with other biomarkers","volume":"15","author":"Reis","year":"2024","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.cca.2025.120418_b0320","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/ajcp\/aqae066","article-title":"\u03b22-microglobulin expression is associated with aggressive histology, activated tumor immune milieu, and outcome in colon carcinoma","volume":"162","author":"Lee","year":"2024","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.cca.2025.120418_b0325","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jmb.2005.11.068","article-title":"Structural basis of the differential stability and receptor specificity of H-2Db in complex with murine versus human \u03b22-microglobulin","volume":"356","author":"Achour","year":"2006","journal-title":"J. Mol. Biol."},{"issue":"5","key":"10.1016\/j.cca.2025.120418_b0330","first-page":"2087","article-title":"Development and antigen specificity of CD8+ cytotoxic T lymphocytes in beta 2-microglobulin-negative","volume":"152","author":"Apasov","year":"1994","journal-title":"MHC Class I-Deficient Mice in Response to Immunization with Tumor Cells, the Journal of Immunology"},{"issue":"3","key":"10.1016\/j.cca.2025.120418_b0335","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1128\/JVI.01999-06","article-title":"Inhibition of heavy chain and &#x3b2;<sub>2<\/sub>-microglobulin synthesis as a mechanism of major histocompatibility complex class I downregulation during epstein-Barr virus replication","volume":"81","author":"Guerreiro-Cacais","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.cca.2025.120418_b0340","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1512509","article-title":"The role of B2M in cancer immunotherapy resistance: function, resistance mechanism, and reversal strategies","volume":"16","author":"Han","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2025.120418_b0345","doi-asserted-by":"crossref","unstructured":"S.L. LYMPHOMA, B-Cell Chronic Lymphoid Leukemias, Atlas of Diagnostic Hematology E-Book (2020) 177.","DOI":"10.1016\/B978-0-323-56738-1.00010-5"},{"issue":"2","key":"10.1016\/j.cca.2025.120418_b0350","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3324\/haematol.2018.200105","article-title":"T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma","volume":"104","author":"Leivonen","year":"2018","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.cca.2025.120418_b0355","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1084\/jem.20031981","article-title":"Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and \u03b3\u03b4 T cells","volume":"199","author":"Street","year":"2004","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0360","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1038\/s41598-021-84465-6","article-title":"B2M overexpression correlates with malignancy and immune signatures in human gliomas","volume":"11","author":"Zhang","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.cca.2025.120418_b0365","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/his.13461","article-title":"Expression pattern of immunosurveillance\u2010related antigen in adult T cell leukaemia\/lymphoma","volume":"72","author":"Asano","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.cca.2025.120418_b0370","doi-asserted-by":"crossref","unstructured":"A.A. Bhat, R. Gilhotra, Y. Singh, S. Sharma, T.d. Jesus Andreoli Pinto, H.G. Ferraz, S.K. Singh, K. Dua, G. Gupta, Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling, Taylor & Francis, 2023, pp. 583-587.","DOI":"10.2217\/nnm-2023-0032"},{"key":"10.1016\/j.cca.2025.120418_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127375","article-title":"A review of glycogen synthase Kinase-3 (GSK3) inhibitors for cancers therapies","volume":"253","author":"Thapa","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.cca.2025.120418_b0380","article-title":"Analysis of the mutational landscape of marginal zone B-cell lymphomas by high throughput sequencing techniques","author":"Vela","year":"2021","journal-title":"University_of_basel"},{"key":"10.1016\/j.cca.2025.120418_b0385","unstructured":"C.-C. Chang, Tumor immune escape: Molecular mechanisms and counteracting strategies, State University of New York at Buffalo, 2005."},{"key":"10.1016\/j.cca.2025.120418_b0390","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fonc.2018.00147","article-title":"The role of macrophage\/B-cell interactions in the pathophysiology of B-cell lymphomas","volume":"8","author":"Pham","year":"2018","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0395","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13045-021-01134-x","article-title":"Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunities","volume":"14","author":"Liu","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.cca.2025.120418_b0400","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/cancers13020210","article-title":"The functional crosstalk between myeloid-derived suppressor cells and regulatory T cells within the immunosuppressive tumor microenvironment","volume":"13","author":"Haist","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.cca.2025.120418_b0405","first-page":"990","article-title":"Hepatocyte growth factor\/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via \u03b14\u03b21 and \u03b15\u03b21 integrins","volume":"89","author":"Weimar","year":"1997","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"3","key":"10.1016\/j.cca.2025.120418_b0410","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10585-019-09966-1","article-title":"The extracellular matrix in tumor progression and metastasis","volume":"36","author":"Eble","year":"2019","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.cca.2025.120418_b0415","unstructured":"L. Broggini, Molecular determinants underlying protein misfolding and aggregation, 2021."},{"key":"10.1016\/j.cca.2025.120418_b0420","unstructured":"I. Jim\u00e9nez Bernal, Tumor immune microenvironment in B-cell lymphoid malignancies, 2020."},{"key":"10.1016\/j.cca.2025.120418_b0425","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12032-014-0185-3","article-title":"Prognostic significance of serum beta-2 microglobulin level in hodgkin lymphoma treated with ABVD-based therapy","volume":"31","author":"Nakajima","year":"2014","journal-title":"Medical Oncology (Northwood, London, England)"},{"issue":"14","key":"10.1016\/j.cca.2025.120418_b0430","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood-2014-08-594689","article-title":"Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1","volume":"125","author":"Lin","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cca.2025.120418_b0435","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1182\/blood.2020010387","article-title":"Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell project","volume":"138","author":"Advani","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0440","doi-asserted-by":"crossref","first-page":"12907","DOI":"10.1038\/s41598-018-31212-z","article-title":"B2 microglobulin is a novel prognostic marker of angioimmunoblastic T-cell lymphoma","volume":"8","author":"Shang","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0445","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4143\/crt.2022.015","article-title":"A new prognostic index for extranodal natural killer\/T-cell lymphoma: incorporation of serum \u03b2-2 microglobulin to PINK","volume":"55","author":"Kang","year":"2023","journal-title":"Can. Res. Treat"},{"issue":"3","key":"10.1016\/j.cca.2025.120418_b0450","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5045\/br.2014.49.3.148","article-title":"Serum beta-2 microglobulin in malignant lymphomas: an old but powerful prognostic factor","volume":"49","author":"Yoo","year":"2014","journal-title":"Blood Research"},{"issue":"8","key":"10.1016\/j.cca.2025.120418_b0455","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/cgt.2014.32","article-title":"Adenovirus expressing \u03b22-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition","volume":"21","author":"Del Campo","year":"2014","journal-title":"Can. Gene Ther."},{"key":"10.1016\/j.cca.2025.120418_b0460","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cca.2022.05.029","article-title":"Molecular markers in cancer","volume":"532","author":"Ahmad","year":"2022","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2025.120418_b0465","doi-asserted-by":"crossref","first-page":"160","DOI":"10.54393\/pjhs.v4i05.757","article-title":"Increased turnover of Beta 2 microglobulin in circulation serves as diagnostic and prognostic marker for malignant lymphoma; a case control predictive model for lymphoma diagnosis: Beta 2 microglobulin as a diagnostic and prognostic marker","author":"Mumtaz","year":"2023","journal-title":"Pakistan J. Health Sci."},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0470","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/hon.2188","article-title":"Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma","volume":"34","author":"Yoo","year":"2016","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.cca.2025.120418_b0475","doi-asserted-by":"crossref","unstructured":"Prognostic Value of Serum \u03b2-2 Microglobulin in Low-Grade Lymphoma, Annals of internal medicine 114(10) (1991) 855\u2013860.","DOI":"10.7326\/0003-4819-114-10-855"},{"issue":"58","key":"10.1016\/j.cca.2025.120418_b0480","doi-asserted-by":"crossref","first-page":"98533","DOI":"10.18632\/oncotarget.21963","article-title":"Blood biomarkers in adults with lymph node enlargement contribute to diagnostic significance of malignancy","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.cca.2025.120418_b0485","first-page":"4114","article-title":"Multi-marker algorithms based on CXCL13, IL-10, sIL-2 receptor, and \u03b22-microglobulin in cerebrospinal fluid to diagnose CNS lymphoma","volume":"9","author":"Maeyama","year":"2020","journal-title":"Can. Med."},{"key":"10.1016\/j.cca.2025.120418_b0490","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx653.010","article-title":"Prognostic significance of serum Beta 2 microglobulin in non-hodgkin lymphoma","volume":"28","author":"Gupta","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cca.2025.120418_b0495","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fmed.2017.00073","article-title":"Rediscovering beta-2 microglobulin as a biomarker across the spectrum of kidney diseases","volume":"4","author":"Argyropoulos","year":"2017","journal-title":"Front. Med."},{"issue":"6","key":"10.1016\/j.cca.2025.120418_b0500","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/15384047.2019.1580414","article-title":"Beta 2-microglobulin regulates amyloid precursor-like protein 2 expression and the migration of pancreatic cancer cells","volume":"20","author":"Sliker","year":"2019","journal-title":"Can. Biol. Ther."},{"issue":"22","key":"10.1016\/j.cca.2025.120418_b0505","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2104504118","article-title":"Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma","volume":"118","author":"Fangazio","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.cca.2025.120418_b0510","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1007\/s10238-023-01061-w","article-title":"Beta2-microglobulin is a valuable marker and identifies a poor-prognosis subgroup among intermediate-risk patients with diffuse large B cell lymphoma","volume":"23","author":"Chen","year":"2023","journal-title":"Clin. Exp. Med."},{"issue":"11","key":"10.1016\/j.cca.2025.120418_b0515","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.leukres.2015.08.016","article-title":"Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy","volume":"39","author":"Miyashita","year":"2015","journal-title":"Leuk. Res."},{"issue":"47","key":"10.1016\/j.cca.2025.120418_b0520","doi-asserted-by":"crossref","first-page":"76934","DOI":"10.18632\/oncotarget.12734","article-title":"Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era","volume":"7","author":"Seo","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0525","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000362670","article-title":"Prognostic significance of serum Beta-2 microglobulin in patients with non-hodgkin lymphoma","volume":"87","author":"Wu","year":"2014","journal-title":"Oncology"},{"issue":"44","key":"10.1016\/j.cca.2025.120418_b0530","doi-asserted-by":"crossref","first-page":"72219","DOI":"10.18632\/oncotarget.12663","article-title":"Prognostic value of pretreatment serum beta-2 microglobulin level in advanced classical hodgkin lymphoma treated in the modern era","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.cca.2025.120418_b0535","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00277-012-1434-1","article-title":"Serum beta2-microglobin is a predictor of prognosis in patients with upper aerodigestive tract NK\/T-cell lymphoma","volume":"91","author":"Li","year":"2012","journal-title":"Ann. Hematol."},{"issue":"9","key":"10.1016\/j.cca.2025.120418_b0540","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12032-014-0185-3","article-title":"Prognostic significance of serum beta-2 microglobulin level in hodgkin lymphoma treated with ABVD-based therapy","volume":"31","author":"Nakajima","year":"2014","journal-title":"Med. Oncol."},{"issue":"21","key":"10.1016\/j.cca.2025.120418_b0545","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1182\/blood.V124.21.3079.3079","article-title":"Beta-2 microglobulin as a strong prognostic factor in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone","volume":"124","author":"Miyashita","year":"2014","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.cca.2025.120418_b0550","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/jclinpath-2012-200742","article-title":"Prognostic impact of \u03b2-2-microglobulin expression in colorectal cancers stratified by mismatch repair status","volume":"65","author":"Koelzer","year":"2012","journal-title":"J. Clin. Pathol."},{"issue":"22","key":"10.1016\/j.cca.2025.120418_b0555","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.3390\/cancers16223744","article-title":"Beta-2-microglobulin maintains overall survival prediction in binet a stage chronic lymphocytic leukemia patients with compromised kidney function in both treatment eras of chemoimmunotherapy and targeted agents","volume":"16","author":"Bohn","year":"2024","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.cca.2025.120418_b0560","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3390\/diagnostics12020394","article-title":"Metabolic biomarkers in B-cell lymphomas for early diagnosis and prediction, as well as their influence on prognosis and treatment","volume":"12","author":"Alfaifi","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.cca.2025.120418_b0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.prmcm.2024.100378","article-title":"Pectolinarigenin and its derivatives: bridging the gap between chemical properties and pharmacological applications","volume":"10","author":"Patel","year":"2024","journal-title":"Pharmacol. Res.-Modern Chinese Med."},{"key":"10.1016\/j.cca.2025.120418_b0570","doi-asserted-by":"crossref","unstructured":"P. Sen, M. Gupta, M. Saini, P. Dave, A.A. Bhat, G. Gupta, Oxidative stress-induced metabolic disorders: mechanism and pathogenesis, Metal Nanocomposites in Nanotherapeutics for Oxidative Stress-Induced Metabolic Disorders, CRC Press, 2024, pp. 1\u201315.","DOI":"10.1201\/9781032621135-1"},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0575","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1186\/s12885-024-12441-0","article-title":"Serum beta2-microglobulin acts as a biomarker for severity and prognosis in glioma patients: a preliminary clinical study","volume":"24","author":"Liu","year":"2024","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.cca.2025.120418_b0580","article-title":"Prognostic value of serum \u03b22-microglobulin in predicting survival of patients with diffuse large B-cell lymphoma","volume":"71","author":"Zhong","year":"2025","journal-title":"Clin. Lab."},{"issue":"2","key":"10.1016\/j.cca.2025.120418_b0585","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/bjh.14237","article-title":"Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum \u03b22-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model","volume":"175","author":"Chen","year":"2016","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.cca.2025.120418_b0590","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s00277-024-05631-0","article-title":"The clinical significance and prognostic value of serum beta-2 microglobulin in adult lymphoma-associated hemophagocytic lymphohistiocytosis: a multicenter analysis of 326 patients","volume":"103","author":"Jin","year":"2024","journal-title":"Ann. Hematol."},{"issue":"3","key":"10.1016\/j.cca.2025.120418_b0595","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1158\/1078-0432.CCR-07-2063","article-title":"The prognostic significance of serum \u03b22 microglobulin levels in acute myeloid leukemia and prognostic scores predicting survival: analysis of 1,180 patients","volume":"14","author":"Tsimberidou","year":"2008","journal-title":"Clin. Can. Res."},{"issue":"4","key":"10.1016\/j.cca.2025.120418_b0600","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/adt.2014.573","article-title":"Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors","volume":"12","author":"Edmondson","year":"2014","journal-title":"Assay Drug. Dev. Technol."},{"key":"10.1016\/j.cca.2025.120418_b0605","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fimmu.2015.00446","article-title":"Modes of antigen presentation by lymph node stromal cells and their immunological implications","volume":"6","author":"Hirosue","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2025.120418_b0610","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1053920","article-title":"Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer","volume":"14","author":"Strating","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0615","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40164-025-00647-2","article-title":"Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer","volume":"14","author":"Zhang","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.cca.2025.120418_b0620","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.molmed.2021.11.006","article-title":"Leveraging cellular mechano-responsiveness for cancer therapy","volume":"28","author":"Hyun","year":"2022","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0625","first-page":"194","article-title":"Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects","volume":"22","author":"Wu","year":"2023","journal-title":"Mol. Can."},{"key":"10.1016\/j.cca.2025.120418_b0630","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.805195","article-title":"Epigenetic, metabolic, and immune crosstalk in germinal-center-derived B-cell lymphomas: unveiling new vulnerabilities for rational combination therapies","volume":"9","author":"Serganova","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"11","key":"10.1016\/j.cca.2025.120418_b0635","doi-asserted-by":"crossref","first-page":"8567","DOI":"10.18632\/oncotarget.3251","article-title":"Anti-\u03b22-microglobulin monoclonal antibodies overcome bortezomib resistance in multiple myeloma by inhibiting autophagy","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.cca.2025.120418_b0640","doi-asserted-by":"crossref","first-page":"940","DOI":"10.4049\/jimmunol.134.2.940","article-title":"Differential effect of anti-beta 2-microglobulin on IL 2 production and IL 2 receptor expression in the primary mixed lymphocyte culture reaction","volume":"134","author":"Chouaib","year":"1985","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cca.2025.120418_b0645","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.139.4.1022","article-title":"Proteolytically modified human beta2-microglobulin augments the specific cytotoxic activity in murine mixed lymphocyte culture","volume":"139","author":"Nissen","year":"1987","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cca.2025.120418_b0650","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1172\/JCI116249","article-title":"Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA","volume":"91","author":"Wang","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2025.120418_b0655","article-title":"Causal relationship between beta-2 microglobulin and B-cell malignancies: genome-wide meta-analysis and a bidirectional two-sample mendelian randomization study","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.cca.2025.120418_b0660","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00277-014-2015-2","article-title":"Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer\/T cell lymphoma","volume":"93","author":"Yoo","year":"2014","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.cca.2025.120418_b0665","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/ijh.ijh_44_20","article-title":"Assessment of beta-2 microglobulin and CD49d in patients with chronic lymphocytic leukemia pre- and posttherapy","volume":"9","author":"Al-Rekabi","year":"2020","journal-title":"Iraqi J. Hematol."},{"issue":"3","key":"10.1016\/j.cca.2025.120418_b0670","first-page":"165","article-title":"The levels of serum C-reactive protein, Beta 2 microglobulin, ferritin, lactate dehydrogenase and some specific proteins in patients with non-Hodgkin's lymphoma before and after treatment","volume":"41","author":"Yildirim","year":"2009","journal-title":"Eurasian J. Med."},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0675","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0022-5347(01)66661-8","article-title":"Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma","volume":"155","author":"Gastl","year":"1996","journal-title":"J. Urol."},{"issue":"10","key":"10.1016\/j.cca.2025.120418_b0680","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.4049\/jimmunol.154.10.5205","article-title":"Dissociation of beta 2-microglobulin from HLA class I heavy chains correlates with acquisition of epitopes in the cytoplasmic tail","volume":"154","author":"Little","year":"1995","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cca.2025.120418_b0685","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.139.4.1022","article-title":"Proteolytically modified human beta 2-microglobulin augments the specific cytotoxic activity in murine mixed lymphocyte culture","volume":"139","author":"Nissen","year":"1987","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cca.2025.120418_b0690","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1158\/2159-8290.CD-20-0987","article-title":"CD4 T cell-dependent rejection of Beta-2 microglobulin null mismatch repair-deficient tumors","volume":"11","author":"Germano","year":"2021","journal-title":"Can. Discov."},{"issue":"6","key":"10.1016\/j.cca.2025.120418_b0695","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/bjh.14489","article-title":"Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of \u03b2(2) -microglobulin yields a more accurate GELTAMO-IPI","volume":"176","author":"Montalb\u00e1n","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"13","key":"10.1016\/j.cca.2025.120418_b0700","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1056\/NEJM198009253031302","article-title":"Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determination","volume":"303","author":"Mavlight","year":"1980","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.cca.2025.120418_b0705","first-page":"e7239","article-title":"Revisiting beta\u20102 microglobulin as a prognostic marker in diffuse large B\u2010cell lymphoma","volume":"13","author":"Jelicic","year":"2024","journal-title":"Can. Med."},{"key":"10.1016\/j.cca.2025.120418_b0710","doi-asserted-by":"crossref","unstructured":"R. Bataille, J. Grenier, J. Sany, Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment \u2013 a prospective study of 160 patients, 1984.","DOI":"10.1182\/blood.V63.2.468.bloodjournal632468"},{"key":"10.1016\/j.cca.2025.120418_b0715","doi-asserted-by":"crossref","unstructured":"A. Raby, K. Moffat, M. Crowther, Anticardiolipin antibody and anti-beta 2 glycoprotein I antibody assays, Haemostasis: Methods Protocols (2013) 387\u2013405.","DOI":"10.1007\/978-1-62703-339-8_32"},{"issue":"7","key":"10.1016\/j.cca.2025.120418_b0720","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1200\/JCO.2006.09.4490","article-title":"Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications\u2014a study from the Lunenburg lymphoma biomarker consortium","volume":"25","author":"de Jong","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cca.2025.120418_b0725","doi-asserted-by":"crossref","unstructured":"R. Sebro, Advancing diagnostics and patient care: the role of biomarkers in radiology, seminars in musculoskeletal radiology, Thieme Medical Publishers, Inc., 2024, pp. 003\u2013013.","DOI":"10.1055\/s-0043-1776426"},{"issue":"6","key":"10.1016\/j.cca.2025.120418_b0730","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.clinbiochem.2012.12.012","article-title":"The role of proteomics in prostate cancer research: biomarker discovery and validation","volume":"46","author":"Pin","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2025.120418_b0735","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-5908-3-13","article-title":"Incorporating clinical guidelines through clinician decision-making","volume":"3","author":"Falzer","year":"2008","journal-title":"Implement. Sci."},{"issue":"3","key":"10.1016\/j.cca.2025.120418_b0740","article-title":"Society for immunotherapy of cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols","volume":"13","author":"Cottrell","year":"2025","journal-title":"J. Immunother. Can."},{"key":"10.1016\/j.cca.2025.120418_b0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2020.151537","article-title":"Abundant CD8+ tumor infiltrating lymphocytes and beta-2-microglobulin are associated with better outcome and response to interleukin-2 therapy in advanced stage clear cell renal cell carcinoma","volume":"47","author":"Davis","year":"2020","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.cca.2025.120418_b0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2018.10.006","article-title":"Available prognostic models for risk stratification of diffuse large B cell lymphoma patients: a systematic review","volume":"133","author":"Jelicic","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.cca.2025.120418_b0755","unstructured":"R. Coutinho, M. Flook, A. Pria, S. Gandhi, K. Bailey, P. Fields, K. Cwynarski, A. Wilson, F. Burns, M. Tenant-Flowers, Non-Hodgkin Lymphoma-Clinical, in: 18TH congress of the european hematology association stockholm, Sweden JUNE 13-16, 2013, 2008, p. 129."},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0760","first-page":"1","article-title":"Predicting progression events in multiple myeloma from routine blood work","volume":"8","author":"Ferle","year":"2025","journal-title":"NPJ Digital Med."},{"issue":"4","key":"10.1016\/j.cca.2025.120418_b0765","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153157","article-title":"Revisiting the middle molecule hypothesis of uremic toxicity: a systematic review of beta 2 microglobulin population kinetics and large scale modeling of hemodialysis trials in silico","volume":"11","author":"Roumelioti","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2025.120418_b0770","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.636568","article-title":"Cancer immune evasion through loss of MHC class I antigen presentation","volume":"12","author":"Dhatchinamoorthy","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cca.2025.120418_b0775","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1158\/1078-0432.CCR-08-1823","article-title":"Human-like mouse models for testing the efficacy and safety of anti-\u03b22-microglobulin monoclonal antibodies to treat myeloma","volume":"15","author":"Yang","year":"2009","journal-title":"Clin. Can. Res."},{"issue":"1","key":"10.1016\/j.cca.2025.120418_b0780","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1515\/cclm-2024-0675","article-title":"Point-of-care testing: state-of-the art and perspectives","volume":"63","author":"Plebani","year":"2025","journal-title":"Clin. Chem. Laborat. Med. (CCLM)"},{"key":"10.1016\/j.cca.2025.120418_b0785","doi-asserted-by":"crossref","DOI":"10.47852\/bonviewMEDIN42022335","article-title":"Bioinformatics applications in chronic diseases: a comprehensive review of genomic, transcriptomics, proteomic, metabolomics, and machine learning approaches","author":"Ogunjobi","year":"2024","journal-title":"Medinformatics"},{"key":"10.1016\/j.cca.2025.120418_b0790","doi-asserted-by":"crossref","unstructured":"R.S. Khan, Z. Khurshid, F. Yahya Ibrahim Asiri, Advancing point-of-care (PoC) testing using human saliva as liquid biopsy, Diagnostics 7(3) (2017) 39.","DOI":"10.3390\/diagnostics7030039"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125002979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125002979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T11:57:59Z","timestamp":1756036679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125002979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":158,"alternative-id":["S0009898125002979"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120418","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beta-2 microglobulin in lymphoma","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120418","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120418"}}